FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
FABP7 | Fatty acid binding protein 7, brain | Predicted intracellular proteins
| | | | | Tissue enriched |
FAM169A | Family with sequence similarity 169, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM83G | Family with sequence similarity 83, member G | Predicted intracellular proteins
| | | | | Tissue enhanced |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FBF1 | Fas (TNFRSF6) binding factor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FDX1 | Ferredoxin 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FHL2 | Four and a half LIM domains 2 | Predicted intracellular proteins
| | | | | Group enriched |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FOXA1 | Forkhead box A1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATM | Glycine amidinotransferase (L-arginine:glycine amidinotransferase) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
H1FX | H1 histone family, member X | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
HMGA2 | High mobility group AT-hook 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Predicted intracellular proteins
| | | | | Group enriched |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
HPGD | Hydroxyprostaglandin dehydrogenase 15-(NAD) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | Predicted intracellular proteins
| | | | | Group enriched |
IGFN1 | Immunoglobulin-like and fibronectin type III domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | | | Tissue enriched |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
JPH1 | Junctophilin 1 | Predicted membrane proteins
| | | | | Tissue enriched |
JUP | Junction plakoglobin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |